XML 10 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Net product sales $ 34,670 $ 29,615
Cost of product sales 8,444 16,854
Gross profit 26,226 12,761
Operating expenses:    
Research and development 4,608 8,836
General and administrative 14,974 15,834
Sales and marketing 11,442 21,154
Total operating expenses 31,024 45,824
Loss from operations (4,798) (33,063)
Other income, net 1,638 295
Net loss (3,160) (32,768)
Other comprehensive loss:    
Unrealized (losses) gains on short-term investments (19) 28
Comprehensive loss $ (3,179) $ (32,740)
Basic net loss per share $ (0.02) $ (0.27)
Weighted average common shares outstanding, basic 151,199 119,246
Diluted net loss per share $ (0.02) $ (0.27)
Weighted average common shares outstanding, diluted 151,199 119,246